Clinical trials
Terminated Lymphoma, Non-Hodgkin trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 5 |
| Bristol-Myers Squibb | 2 |
| IGM Biosciences, Inc. | 2 |
| MEI Pharma, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| ADC Therapeutics S.A. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Biomea Fusion Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 36 |
| Lymphoma | 13 |
| Lymphoma, Large B-Cell, Diffuse | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Recurrence | 8 |
| Neoplasms | 7 |
| Leukemia | 6 |
| Lymphoma, T-Cell, Peripheral | 5 |
| Hodgkin Disease | 4 |
| Leukemia, Myeloid, Acute | 4 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.